Department of Oncology 2018 Annual Report

Department
of Oncology

2018 ANNUAL REPORT

Y

CINE

UNIVERSITY OF CALGARY

CUMMING SCHOOL OF MEDICINE
Department of Oncology

1 DEPARTMENT OF ONCOLOGY

Message from Head, Department of Oncology

Dr. Sunil Verma This year marks another milestone for the Department of Oncology research. With this focus, we launched the seed grant competition and
and its members. We surpassed > 500 publications, more than we are pleased to offer five grants to teams that will conduct research
Professor and Head, Department > $50 million in grant funding and > 500 trainees come through our aligned with our strategic priorities. We also formed working groups in
of Oncology Cumming School of educational programs. The remarkable achievements by our members areas of strength and have supported exchange of ideas to formulate
Medicine, University of Calgary highlights the great talent, expertise, and effort that will continue to the next phase of Departmental research ideas and these will be
steer the research and academic programs over the next decade and supported through the next wave of funding to support these efforts.
Medical Director, Tom Baker Cancer into and beyond the build of the new Cancer Centre.
Centre, CancerControl Alberta, Along with excellence in research domains, we also continue to support
Alberta Health Services The year also marked our continued effort to strengthen and position educational programs that will help prepare us for the future needs
ourselves at the national and global academic stage by attracting of cancer care and train the next generation of clinicians. Under the
Vision key leaders. Dr. Lisa Barbera joined us from Sunnybrook Odette guidance of Dr. Vince Tam and with support from many members
in September 2018 as the Division Head of Radiation Oncology. of our Department, we will officially launch a fellowship program for
Creating a future without cancer. Dr. Barbera has already helped to formulate and launch the key General Practitioners in Oncology. This program will be instrumental
research priorities for the Division. This year also marks transition in in helping us develop new models of clinical care and integration of
Mission key leadership roles in our Department. Dr. Daniel Heng assumed the clinical services within the current cancer system and also support
role as Medical Lead for the Clinical Research Unit from Dr. Gwyn Bebb. growing needs across the province. Dr. Amanda Rose Des Ordons and
To improve cancer patient care The growth of clinical trials program is essential for us to contribute members of the Division of Palliative Medicine also established the
and health outcomes through and participate in novel studies and offer these to our patients so official Royal College specialty program for Palliative Medicine and we
integrated programs in cancer that they can have access to these therapies and help transform enrolled our first resident in this program. We also saw ongoing growth
prevention, patient care, the future of Cancer Care. Dr. Paola Neri is also starting her role as in number of fellows joining our Department from across the globe and
research, and education. Scientific Director for the Precision Oncology Hub and will be leading we will continue to grow our fellowship program given the strength of
the program (previously referred to as Translation Lab) that will help our mentors and expertise within our Department.
us provide the technology, expertise, and skills to support translational
and precision based efforts within and in partnership with a number of This year was also pivotal as we saw the start of the build process of
key precision medicine efforts taking place within AHS and University the new Calgary Cancer Centre. This has been a tremendous effort
of Calgary. We thank Dr. Don Morris for his years of service and with engagement across key stakeholders and many members of our
leadership in this role and will look to him for his support as we grow Department. The design process is also well underway to help shape
this research program. the care and integration of research and education that will help us
provide a comprehensive approach and will accelerate research efforts
We also saw growth of a number of research programs over the across multiple domains.
course of the year. The Alberta Cancer Outcomes Research Network
(ACORN) under the leadership of Drs. Winson Cheung, May Lynn Our members have continued to shine at the national and global
Quan and Joe Dort, launched a number of research studies along with stage. There were a number of pivotal awards, presentations and
being awarded funding and support through this year and now has an leadership positions held by members of the department across all
established footprint with scientists and researchers housed together. Divisions. The following report will highlight many of these awards and
The Precision Oncology and Experimental Therapeutics (POET) achievements. It is important to recognize that while at times awards
program also grew with the launch of several research initiatives acknowledge individual achievements, our true strength has been
and national collaborations to set the stage for future key projects. driven by a culture of collaboration, leadership, support and innovation
The POET 2018 meeting was a huge success and drew international and the future is bright as we build on these strengths of our individual
speakers and attendees with a focus on key precision oncology members and this collective spirit.
efforts in Alberta. In order to position us for future success and meet
the needs of our researchers, we established the Oncology Research Sincerely,
Office (ORO). ORO program is designed particularly to facilitate, enable
and support clinical research that will enhance multi-disciplinary

ANNUAL REPORT 2018 2

Table of Contents 1
3
Message from Department Head 4
Strategic Plan 5
Leadership 7
Academic Awards 8
Academic Achievements 9
Academic Activity 10
Staff Profile and New Recruitments 11
Education Profile
Oncology Education Program 13
Divisions of Oncology 15
17
Gynecologic Oncology 19
Hematologic Oncology 21
Medical Oncology 23
Medical Physics 25
Palliative Medicine 27
Pediatric Oncology 29
Preventive Oncology 31
Psychosocial Oncology 33
Radiation Oncology 35
Surgical Oncology 37
Precision Oncology Hub 41
Oncology Research Office 43
Calgary Cancer Project
Department of Oncology Members
Partners

3 DEPARTMENT OF ONCOLOGY

Strategic Plan

Strategy Framework Vision

We will achieve our vision and mission Creating a future without cancer
through our Research FOCI, Strategic
Pillars and Enabling Strategies

Mission

To improve cancer patient care and health outcomes through integrated
programs in cancer prevention, patient care, research, and education.

Research FOCI

Precision Psychosocial Prevention and Alberta Cancer Innovative Clinical
Oncology and and Survivorship Risk Reduction Outcomes Radiation Research Unit
Experimental Research and Surgical
Therapeutics Research Network Techniques (CRU)
(ACORN)
(POET)

Strategic Pillars

Advancing our Embracing Building Capacity, Fostering Team
Research FOCI our Research Mentoring and Work and
Leadership Culture Supporting
Researchers Collaboration

Enabling Strategies

Funding
Infrastructure
Communication and Profile

ANNUAL REPORT 2018 4

Leadership

Provincial and Calgary Leadership Roles - 2018

Department of Oncology Leadership Dr. Wendy Smith Leadership Appointments
Dr. Sunil Verma Division Head, Medical Physics Dr. Ernesta Paola Neri
Department Head (Clinical and Academic) Scientific Director, Precision Oncology Hub
Medical Director, TBCC Dr. Jessica Simon
Medical Lead, Calgary Cancer Project Division Head and Section Chief, Dr. Daniel Heng
Palliative Medicine Medical Lead, Clinical Research Unit
Dr. Peter Duggan
Division Head and Section Chief, Dr. Victor Lewis Dr. Doug Stewart
Hematologic Oncology Division Head and Section Chief, Senior Medical Director Cancer SCN
Deputy Clinical Department Head Pediatric Oncology
Deputy Medical Director, TBCC D­ r. Winson Cheung
Dr. Christine Friedenreich Medical Director, Provincial Health
Dr. Lloyd Mack Division Head, Preventive Oncology Services Research, CancerControl
Deputy Academic Department Head Alberta; Co-Program Lead, ARCC,
Dr. Barry Bultz HSSP Research Program
Dr. Tien Phan Division Head, Psychosocial Oncology
Associate Medical Lead,
Calgary Cancer Project Dr. Lisa Barbera
Division Head and Section Chief,
Dr. Vincent Tam Radiation Oncology
Associate Director of Education
Dr. Greg McKinnon
Dr. Gregg Nelson Division Head and Section Chief,
Division Head and Section Chief, Surgical Oncology
Gynecologic Oncology

Dr. J. Dean Ruether
Medical Director, Community Oncology

Dr. Don Morris
Division Head and Section Chief,
Medical Oncology
Acting Scientific Director,
Translational Laboratories

5 DEPARTMENT OF ONCOLOGY

Academic Awards

Department of Oncology Awards - 2018

Young Dr. Darren Brenner
Investigator
This award recognizes an individual who shows evidence of success in publication, grant
Award awards, ongoing impact in cancer research and acknowledged credibility within the field of
discipline he or she practices. The nominee must be in their first five years of their academic
career post residency/fellowship.

Gavin Stuart Dr. Michael Speca
Award
This award recognizes an individual who combines clinical excellence (acute diagnostic,
for Clinical sound clinical judgement, caring bedside manner, respected by colleagues and considered a
Excellence & role model) with the highest professional conduct (commitments to professional competence
Professionalism and responsibilities, honesty, patient confidentiality, improving access and quality of care,
ethical allocation of finite resources, involvement at organizational level in improving cancer
care delivery and managing conflicts of interest).

Luminary Dr. Prafull Ghatage
Award for
Teaching This award recognizes an individual who has shown an ability to connect significantly with
individuals or groups of trainees. Characteristics including sustained teaching excellence,
mentorship, supervision and educational scholarship are considered. Impact over protracted
time period will be a significant help to deciding this award.

ANNUAL REPORT 2018 6

Academic Awards

Team Award Team OASIS
for Innovation
This award recognizes a team that has demonstrated a commitment to improving the
delivery of quality health care within the department including effectiveness, efficiency, equity,
patient centeredness, safety and timeliness. The work of this group may have demonstrated
leadership in creating or implementing an innovative program, medical treatment or teaching
that has improved the lives of patients.

Amy Driga Dr. Andrea Beck Ashley Ayume Carly Sears Dr. Corinne Doll Dr. Ericka Wiebe Dr. Jill Turner Dr. John Robinson

Kerrie Brennan Dr. Lauren Walker Natalie Jacox Reanne Booker Dr. Roanne Millman Dr. Sarah Glaze Dr. Tien Phan

7 DEPARTMENT OF ONCOLOGY

Academic Achievements

Academic Promotions

MEDICAL MEDICAL
ONCOLOGY PHYSICS
GYNECOLOGIC
ONCOLOGY

Dr. Don Morris Dr. Daniel Heng Dr. Vincent Tam Dr. David Spencer Dr. Prafull Ghatage
Professor (GFT) Clinical Professor Clinical Associate Honorary Adjunct Professor (GFT)
Professor Assistant Professor

RADIATION PREVENTIVE
ONCOLOGY ONCOLOGY
PALLIATIVE
MEDICINE

Dr. Ivo Olivotto Dr. Corinne Doll Dr. Harvey Quon Dr. Melissa Shea-Budgell Dr. Shane Sinclair
Honorary Clinical Clinical Professor Clinical Associate Adjunct Assistant Adjunct Associate
Professor Professor Professor Professor

SURGICAL HEMATOLOGIC
ONCOLOGY ONCOLOGY

Dr. Walley Temple Dr. Shamir Chandarana Dr. Gary Gelfand Dr. Antoine Dr. Mona Shafey Dr. Paola Neri
Professor Emeritus Clinical Associate Clinical Associate Bouchard-Fortier Clinical Associate Associate Professor
Professor Professor Clinical Assistant Professor
Professor

ANNUAL REPORT 2018 8

Academic Activity

Grants - 2018 Number of Grants Grant Amount Total 2018 grant amount
41 $5,949,699
Division 28 $6,907,044 $59,892,225
Fundamental Research 11 $2,959,200
Gynecologic Oncology 39 $5,730,082
Hematologic Oncology 2 $226,205
Medical Oncology 17
Medical Physics 35 $1,696,777.33
Palliative Medicine 6 $161,298
Pediatric Oncology 32
Precision Oncology Hub 35 $500,000+
Preventive Oncology 10 $28,908,254
Psychosocial Oncology 12
Radiation Oncology 227 $5,065,383
Surgical Oncology $771,823
TOTAL
$7,466,159
$59,892,225

Academic Publications - 2018

Fundamental Research 36 Total 2018 publications
Gynecologic Oncology 30
Hematologic Oncology 91 563
Medical Oncology 146
Medical Physics 14
Palliative Medicine 32
Pediatric Oncology 22
Precision Oncology Hub 10
Preventive Oncology 61
Psychosocial Oncology 68
Radiation Oncology 46
Surgical Oncology 43
TOTAL 563

9 DEPARTMENT OF ONCOLOGY

Staff Profile and New Recruitments Dr. Miranda Fidler
Preventive
Staff New Recruitments Oncology

46 Dr. Lisa Barbera Dr. Salman M. Dr. Natalie Logie Dr. Peter Colbert
69 Radiation Faruqi Radiation Hematology
Oncology Radiation Oncology
118 Oncology Dr. Dwip Prajapati
Dr. Lin Yang Dr. Cheryl Peters Hematology
Academic GFT vs. Preventive Dr. Sarah Quirk Preventive
Clinical Members Oncology Medical Physics Oncology Dr. Ghazaleh
Shoja Razavi
Academic GFT Dr. Ekaterina Dr. Leslie Skeith Dr. Safiya Karim Hematology
Clinical Tchistiakova Hematology Medical
Adjunct Medical Physics Oncology
Department of Dr. Philip
Oncology – 233 members Dr. Jonatan Snir McGeachy Dr. Adam Blais
Medical Physics Medical Physics Medical Physics
91
142

Gender Distribution
Department of Oncology

Female
Male

ANNUAL REPORT 2018 10

Education Profile

Education 40 Education Statistics Since 2016
32 411
16/17 15 431
32 483
Legend 17/18 20
Fellows 18/19 20
Residents
Trainees

2018/19 Division Education Statistics

18/19 Gynecologic Hematologic Medical Medical Palliative Pediatric Psychosocial Radiation Surgical
Oncology Physics Medicine Oncology Oncology Oncology Oncology
Oncology Oncology
1 0 3 4 2 1
Fellows 2 2 8
3 0 4 1 5 3
Residents 7 4 6
9 138 0 19 48 27
Trainees 58 60 74

11 DEPARTMENT OF ONCOLOGY

Oncology Education Program 2018 Program Directors

Dr. Vincent Tam, BSc(Hon), Highlights Alana Hudson
MD, FRCP(C) Medical Physics
Associate Director Planning for the Alberta General Practitioner in Oncology Focused Training Program Dr. Prafull Ghatage
of Education began in the fall of 2018. The goal of this program is to improve the cancer-related Gynecologic Oncology
education of family physicians and provide them with the necessary skills to Dr. Lloyd Mack
Education Statistics proficiently function as members of the cancer care team. Such physicians may go on Surgical Oncology
to work in an urban hospital setting or oncology clinic, or may provide cancer services Dr. Greg Guilcher
Trainees to patients in rural communities which are areas that generally lack oncologists. Pediatric Oncology
489 Dr. Gloria Roldan-Urgoiti will serve as the program director of this program at the Dr. John Robinson
Residents University of Calgary and our first trainees in this program will start in July 2019. Psychosocial Oncology
32 Dr. Mona Shafey
Fellows The new combined curriculum format continues to be quite successful in terms of Hematologic Oncology
23 attendance and evaluations. The current format includes lectures regarding clinically Dr. Shaun Loewen
Rotating Residents/ relevant oncology topics during the first week of July and research topics in the first Radiation Oncology
Students week of September. Dr. Amanda Roze des Ordons
431 Palliative Medicine
Residents and Fellows Research Day was held on June 15, 2018. 19 residents Dr. Jan-Willem Henning
and fellows representing 7 oncology divisions presented their research. The best Medical Oncology
presentations were awarded to Dr. Eve Lyn Langlais (Gynecologic Oncology), Dr. Scott
Hurton (Surgical Oncology) and Dr. Kevin Martell (Radiation Oncology). 2018 Fellowship Directors

We continue to observe a large number of trainees coming through our department. Dr. Safi ya Karim
A total of 20 fellows were in the Department of Oncology in 2018 and they were Medical Oncology
funded through Alberta Cancer Foundation, Department of Oncology, the Lillian Koch Dr. Andrew Daly / Dr. Lynn Savoie
Gynecologic Oncology Fellowship, supervisor research grants and locum funding. Bone Marrow Transplant (BMT)
Dr. Lesley Street
The new Grand Rounds format implemented in 2016 continues to be successful. They Lymphoma
are held once a month and focus on a practice changing topic within each division. Dr. Harvey Quon
Starting In the fall of 2018 we also added additional Grand Rounds to review changes Radiation Oncology
in the management of common cancer disease sites, such as GI, GU, breast and lung.
These sessions were very well attended and we hope to include additional disease site
updates in 2019.

ANNUAL REPORT 2018 12

Department of Oncology Trainees RADIATION ONCOLOGY
MEDICAL ONCOLOGY
GENERAL SURGICAL ONCOLOGY

GYNECOLOGIC ONCOLOGY

MEDICAL PHYSICS PEDIATRIC HEMATOLOGY/ONCOLOGY PSYCHOSOCIAL ONCOLOGY

HEMATOLOGY ONCOLOGY

13 DEPARTMENT OF ONCOLOGY

Gynecologic Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Gregg Nelson, MD, PhD The section of Gynecologic Oncology is composed of 6 members who are active in Dr. Prafull Ghatage: Promotion to Professor
FRCSC clinical gynecologic oncology, research, education and service. Dr. Gregg Nelson (July 1, 2018) Luminary Award for Teaching
took over from Dr. Jill Nation as Section Chief of Gynecologic Oncology on (Department of Oncology, 2018)
Deputy Section Chief July 1, 2018. Dr. Nation continues in her role as the Medical Director of Colposcopy,
and/or Division Head: in the Calgary Zone. Dr. Ghatage is the Fellowship Program Director, Gyn/Onc Dr. Jill Nation: ASCCP (American Society of
Dr. Prafull Ghatage, MD, Tumour Group Lead, and also serves as Deputy Section Chief. Dr. Pamela Chu Colposcopy and Cervical Pathology) - long
FRCSC, Tumour Group stepped down as the Assistant Dean, Postgraduate Medical Education at the service award (2018)
Leader Cumming School of Medicine and has recently been appointed Associate Dean,
Office of Professionalism, Equity, and Diversity. Dr. Sarah Glaze is now the Dr. Sarah Glaze: AHS President’s Excellence
Division Statistics Program Director for the Department of Obstetrics & Gynecology Residency Award Nominee, 2018. Category: Innovation
Program. Dr. Anna Cameron recently joined our group as a Clinical Lecturer. (Integrative Ovarian Cancer Service: Go-BRCA)
Staff She is currently completing a postdoctoral fellowship in Health Economics in the Team Award for Innovation - OASIS (Oncology
6 Department of Community Health Sciences. and Sexuality, Intimacy and Survivorship)
Publications Department of Oncology, 2018
30
Grants Dr. Gregg Nelson: Nominee, 2018 Alumnus of
28 Distinction Award (Cumming School of Medicine)
Value of Grants “In recognition of outstanding contributions
$6,907,044 to research”
Presentations/
Symposiums
30

ANNUAL REPORT 2018 14

Strategic Planning/Priorities

1. Stable funding for 3rd year of the Gynecologic Oncology Fellowship training Program to
enhance research opportunities and academic development for our fellows and make them
competitive for recruitment after completion of fellowship.

2. Recruitment planning for Academic Gynecologic Oncologist – 2 year timeline.

“Our Royal College approved

fellowship program attracts high

Clinical Highlights Research Highlights quality applicants from Canada

Dr. Sarah Glaze has been instrumental in Dr. Nelson continues to provide leadership for our group and abroad. We currently have
the Go BRCA pilot – a QI grant with medical in the Enhanced Recovery after Surgery (ERAS) program,
genetics which was implemented in our which has been implemented in our division now for 2 7 fellows in our program with
division under her leadership and is now years. The TBCC Gynecologic Oncology group is leading
being rolled out to standard practice with this initiative internationally as Dr. Nelson is the Chair of two completing Master’s Degrees
national interest in the pilot project. the Gynecology Section at ERAS International which is
based in Sweden. Dr. Nelson is the principal investigator of at Harvard Medical School and
Dr. Nation is involved in piloting electronic several AIHS and CIHR grants.
colposcopy charting, liaising with the the London School of Economics.
Women’s Health Centre colposcopy clinic as Dr. Ghatage provides leadership in our division from the
well as reintroducing colposcopy pre-invasive standpoint of gynecologic oncology clinical trials at a Our trainees are very competitive
procedures at the Holy Cross Clinic which national level. He was local principal investigator for 9
is anticipated to decrease pressure on wait funded clinical trials in this reporting period while the other in finding academic positions in
times for these cases in the operating rooms. four gynecologic oncologists participate in all trials as
local sub-investigators. Dr. Ghatage is also the Principal gynecologic oncology across the
Investigator for a HiPEC pilot, an innovative intraoperative
chemotherapy approach for ovarian cancer. world when they are finished

Our division published 30 manuscripts in 2018 as well at TBCC.”
as giving 29 presentations and was involved in research
projects with fellows in our training program resulting - Dr. Gregg Nelson
in presentations at the Department of Obstetrics and
Gynecology and Department of Oncology Research Days.

15 DEPARTMENT OF ONCOLOGY

Hematologic Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Peter Duggan, MD, FRCPC The Division of Hematology and Hematological Malignancies Hematology consists Dr. Lynn Savoie: Honorary Consultant,
of 32 members supporting clinical and academic programs that care for patients Haematology St Bartholomew’s Hospital, London
Deputy Section Chief with both benign and malignant disorders. Our cancer programs include myeloma
and/or Division Head: & plasma cell disorders, leukemia & myeloproliferative neoplasms, lymphoma, Dr. Dawn Goodyear: Faculty Appreciation
Dr. Andrew Daly, Director and bone marrow transplantation, while programs in benign hematology include Award, Class of 2019 Cumming School of
Provincial Bone Marrow thrombosis, immune deficiencies, and the Rare Blood and Bleeding Disorders Medicine, University of Calgary
Transplant Program program. We provide consult service to all four major hospitals in Calgary (PLC,
SHC, FMC, RGH), outpatient clinics at FMC, TBCC, PLC, and SHC, and inpatient Dr. Kareem Jamani: University of Calgary
Dr. Carolyn Owen, units at FMC and PLC. In addition we provide outreach clinics at the Margary E. Medicine Class of 2019 Faculty Honor Roll for
Hematology Tumour Group Yuill Cancer Center in Medicine Hat. Between all programs, the division received UME Teaching
Lead more than 6000 new referrals in 2018.
Dr. Kareem Jamani: Certificate in Clinical
Dr. Man-Chu Poon, Director Being leaders in clinical medicine requires leadership in research and innovation. effectiveness, Harvard School of Public Health
Rare Blood and Bleeding The Division of Hematologic Oncology and Hematological Malignancies remains
Disorders Program focused on ensuring that the most cutting edge clinical trials, translational Dr. Deepa Suryanarayan: CIHR Early
research, and novel therapies are available for patients. We are leaders in cancer Career Investigator Observership program
Dr. Deepa Suryanarayan, clinical trials accrual with approximately $3 million annually in clinical trials recipient 2018
Thrombosis Program Lead funding. In 2018 under the direction of Dr. Andrew Daly, the first steps were taken
to develop a CAR-T cell program in Alberta. The first CAR-T cell treatments at the Dr. Deirdre Jenkins: Associate Certificate in
Division Statistics TBCC are expected to take place as part of a clinical later in 2019. Leadership and Conflict Resolution, Justice
Institute of British Columbia
Staff
32 Dr. Leslie Street: Certification in Patient Safety
Publications and Quality Management
91
Grants Dr. Sylvia McCulloch: Completed Master’s of
11 Science at London School of Economics (Health
Value of Grants Economics, Policy and Management)
$2,959,200
Presentations/
Symposiums
87
Book Chapters
6

ANNUAL REPORT 2018 16

“Being a leader in clinical medicine requires
leadership in research and innovation” - Dr. Peter Duggan

Clinical Highlights Research Highlights Dr. Andrew Daly

Hematology has been experiencing steady growth 2018 saw the continuation of our successful clinical
in the number of new referrals, follow up and trials program with more than 30 active trials accruing
treatment patients, and this trend continued in almost 250 patients. In addition to leading in clinical
2018. Despite these increasing demands, we remain trials accrual, the myeloma program saw significant
committed to excellence in clinical care in Calgary new peer reviewed grants awarded from the Multiple
and Southern Alberta. New recruitment in 2018 has Myeloma research Foundation and Terry Fox Research
helped strengthen these programs, with the arrival of Institute to Dr. Paola Neri and Dr. Nizar Bahlis. Dr. Bahlis
Dr. Meghan Drew-McKinstry at SHC and TBCC, and was an invited speaker at 8 national or international
Dr. Sylvia McCulloch at PLC and TBCC. Dr. Ghazaleh meetings, had 21 peer reviewed publications, and was
Razavi joined the Jack Ady Cancer center in Lethbridge PI for 8 clinical trials in 2018. Dr. Neri was invited to
while Dr. Dwip Prajapati joined the staff at the Central speak and present at numerous international meetings
Alberta Cancer Center in Red Deer. including the 2018 American Society of Hematology
annual meeting. Other significant research award
Dr. Leslie Skeith joined the division’s thrombosis recipients include Dr. Jan Storek for work in the
program, and along with Dr. Deepa Suryanarayan prevention of graft versus host disease.
will participate in a growing program that provides
expertise in many areas of thrombosis including
thrombosis in the cancer patient.

17 DEPARTMENT OF ONCOLOGY

Medical Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Don Morris, MD, PhD, Medical Oncology continues to be challenged with clinical service demands Dr. Daniel Heng: Meritorious Service Cross,
FRCPC with increasing new patient and follow up/treatment patient numbers. This has Governor General of Canada
stressed both individual clinics and systemic treatment areas. There has only been Dr. Gloria Roldan-Urgoiti: Clinical Preceptor
Deputy Section Chief 1.6 FTE newly funded medical oncology staffing over the last six years however Education Award, Pfizer
and/or Division Head: we have been able to utilize clinical associates (CA) and nurse practitioners (NP) Dr. Desiree Hao: Medical Oncology Fellows’
Dr. Jan-Willem Henning, and streamline clinic processes/patient follow up to accommodate. In addition the Teaching Award, Pfizer Evidence Based
MBChB, FRCPC use of funds freed up from seconded positions has allowed contracted MO FTE Medicine Preceptor
to be created. The use of CA/RN/NP run clinics for select patient populations Dr. Winson Cheung: Ralph Meyer Investigator
Division Statistics and increased hours and days of operation will be looked at in 2019 to provide Award, Canadian Cancer Trials Group
increased cost effective capacity. Targeted recruitment into the area of health Dr. Sunil Verma: Distinguished Alumni Award,
Staff service research has allowed investigation into best patient care and has elevated Department of Oncology, University of Alberta
28 academic productivity significantly. The creation of the department research office
Publications has facilitated grant/ethics application administration and the implementation of a Research Highlights
146 universal consent for cancer patients should yield dividends over the next several
Grants years in the areas of precision medicine and health research services. A new An outstanding academic performance within Medical
39 academic evaluation metric will be rolled out in 2019 that transparently quantifies Oncology was realized in 2018. With the Division
Value of Grants academic productivity and allows merit based allocation of protected time for our publishing 146 journal articles and 83 abstracts with
$5,730,082 medical oncologists. In addition, the formalization of an educational leave program over 24 million dollars in cumulative grants. In part
Presentations/ was rolled out in the summer of 2017 supported by locum tenens recruitment this degree of success was facilitated by our 9 Medical
Symposiums (Drs. Pabani, Samawi and Alghamdi). Academic and clinical support for our Oncology fellows and availability of locum clinical
80 Medical Oncology Divisional colleagues in Lethbridge, Medicine Hat and Red Deer support by Drs. Samawi/Pabani/Thiessen. In particular
Book Chapters in the form of Medical Oncologists travelling to associate centers to provide clinical Dr. Omar Abdelsalam working with Dr. Cheung had
3 care, as well as, support for clinical trials and collaborations with the TBCC in the over 30 publications himself. Several of our fellows
areas of best practice and health services research is ongoing. were also recipients of ASCO merit awards. A number
of new peer reviewed grants were also awarded to
Drs. Morris, Cheung, Hao, Roldan, Nixon, Karim, Tam,
Alimohamed, Stewart, Verma and Heng. Overall it was
an exceptional academic year for the group.

ANNUAL REPORT 2018 18

“Another exceptional year
for our Medical Oncology
Division. Productivity in
the form of Grant funding/
Publications/Invited
publications have all increased all in
the setting of provision of a quality
based best practice expanding clinical
workload. With ongoing Medical
Oncology staff recruitment and
new initiatives 2019 is looking even
more exciting.” - Dr. Don Morris

Clinical Highlights EMR transition and Dr. Desiree Hao was elected as the new Vice –chair of the Canadian
Association of Medical Oncologists (2018/2019). The above highlights and the many other success
Medical Oncology saw over 3500 new consults in 2018 up from 2915 in 2015. Patient follow-ups stories within Medical Oncology has truly made 2018 a memorable year. Competence Based
over the same period 36,900 vs 32,510 which translated into approximately 180 new patient by Design (CBD) medical education is a new training philosophy initiative set forth by the Royal
consults per funded FTE. The successful recruitment of Dr. Safiya Karim joining our Medical College of Physicians and Surgeons of Canada in 2015. Drs. Henning and Alimohamed have
Oncology membership in 2018 has been a real highlight. Dr. Karim comes to us from Heath led the launch of the Medical Oncology Residency Training Program CBD model July 2018, with
Services Research Fellowship training with Dr. Chris Booth at Queen’s University and has already the 4 new incoming Medical Oncology Residents (PGY-4). Under their leadership, the training
been very productive with 11 publications in 2018 and has been instrumental in several clinical program had to restructure the curriculum, create a Competence Committee and implement the
process initiatives such as PACEs and Integrative Oncology. Awards have also been garnered use of the electronic evaluation platform, ePortfolio. All the faculty and residents were instructed,
by Drs. Gloria Roldan-Urgoiti and Desiree Hao for our annual Pfizer Medical Oncology Fellows trained and equipped during 2 workshops, several one-on-one meetings and several Grand Round
Teaching Awards for Clinical Preceptor and Evidenced Based Medicine preceptor of the year, presentations. Dr. Henning participated in Royal College Medical Oncology National Curriculum as
respectively. Dr. Heng received the very prestigious Governor General Meritorious Service Award well the CBD implementation subcommittees. Similarly our Medical Oncology Fellowship program
for his international standing and contributions in the area of renal cell carcinoma. Dr. Winson lead by Dr. Karim has expanded to 9 Fellows in 2018 and have helped contribute to best practice
Cheung was awarded the Canadian Cancer Trials Group, Ralph Meyer Investigator Award for his and academic success.
work nationally and internationally in the Health Services domain and joins Dr. Patricia Tang as a
recipient of this prestigious award (2016). Dr. Tsang has helped lead us through the ConnectCare

19 DEPARTMENT OF ONCOLOGY

Medical Physics

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Wendy L. Smith, PhD, Our division experienced major changes in personnel in 2018. Our longest serving member, Amy Frederick: NSERC Post-Graduate
FCCPM, MCCPM Dr. David Spencer, retired in December after 25 years at the University of Calgary and the Doctoral Scholarship
Tom Baker Cancer Centre. We welcomed three new permanent physicists to our division: Dean’s Doctoral Scholarship
Division Statistics Dr. Ekaterina Tchistiakova in August and Dr. Jon Snir in October. Dr. Philip McGeachy Department of PHAS Top-Up
completed his Sarcoma fellowship and joined the staff in the Division in March. In addition, COMP Student Travel Award
Staff Dr. Jean-Guy Belliveau completed his residency in September and has accepted a position
28 as a medical physicist in Georgia. Dr. Peter Martin enrolled in the residency program in Rebecca Frederick: Alexander
Publications September. In addition, Dr. Adam Blais joined our department in a Locum role in November. Graham Bell Canada Graduate
14 Dr. Charlie Kirkby was promoted to Associate Professor, and Dr. Nicolas Ploquin was Scholarship - Master’s
Grants awarded the distinction of Fellow of the Canadian College of Physicists in Medicine. Our Program (NSERC)
2 division also hosted Dr. Elizabeth Watt’s fellowship prostate brachytherapy and machine Faculty of Graduate Studies
Value of Grants learning research associate, Jan Rubak. Master’s Scholarship
$226,205 Departmental Graduate Student
Presentations/ Excellence Award
Symposiums
30 Clinical Highlights

The focus for 2018 was on the development and implementation of clinical Our group underwent a major re-organization, merging our radiotherapy computer
techniques to improve patient care. Our first prostate cancer patient was applications support and equipment support groups. The Integrated Radiotherapy
treated with high dose rate brachytherapy in January, and by the end of the Information Systems group has focused on developing and implementing automation
year, this program was operating at full clinical capacity. In addition, our to ensure consistency and improve efficiency in treatment plan reviews. In plan
breast brachytherapy program resumed after a multi-year hiatus, offering deliverability quality assurance, was are shifting from patient specific measurements to
single day treatment for breast radiotherapy patients. The stereotactic machine specific measurements where appropriate to improve efficiency as well.
radiosurgery program upgraded the patient immobilization equipment and
processes, as well as the patient monitoring system. These improvements are A substantial effort went into modernizing the outdated equipment at TBCC in 2018.
intended to improve the quality, comfort and efficiency of patient treatments. One of our linear accelerators, unit 3, was replaced and began treating patients in
Ongoing process review and development continued, with projects such as the April 2018. The stereotactic radiosurgery program was fully commissioned on this
implementation of the six degree of freedom couch for head and neck patients unit, providing a matched pair of treatment devices for both stereotactic treatments of
and a review of imaging for late stage lung cancer patients. Our breast the body and brain. At the end of the year we removed unit 8 from service to renovate
treatment program supported visits from Moncton and Manitoba to review and the vault. New, high dose rate treatment capabilities were commissioned on several
learn from our deep-inspiration breath hold technique. treatment units for faster patient treatments. Major equipment updates will continue
in 2019, and are anticipated to provide the necessary capabilities for modern, effective
radiotherapy in the last 4 years of treatment at the Tom Baker Cancer Centre.

ANNUAL REPORT 2018 20

Awards and Achievements Steven Nich: Queen Elizabeth II Scholarship Dr. Elizabeth Watt: Graduate Assistants
Alberta Graduate Student Scholarship (Teaching) Award at University of Calgary,
Alexandra Guebert: Queen Elizabeth II Scholarships Pembina Honours Scholarship Department of Physics and Astronomy
Departmental Graduate Student Excellence Award FGS Travel Award Celebration of Teaching
Graduate Student Excellence Award
Svetlana Kuznetsova: Queen Elizabeth II Scholarships Academic Project Support Grant Sarah Weppler: NSERC: Alexander Graham
Departmental Graduate Student Excellence Award Bell Award
AMPA Student Travel Award Kailyn Stenhouse: Physics and Astronomy University of Calgary Graduate Students’
Best Presentation Award of IOMP for the presentation Departmental Recruitment Scholarship Association Prof. Development Grant
“Multimodality image fusion of the liver using structure-guided
deformable registration AI-what is the preferred approach?” Lingyue Sun: Departmental
World Congress on Medical Physics and Biomedical Engineering Recruitment Scholarship
June 3-8, 2018, Prague, Czech Republic Departmental Graduate Student
Excellence Award
Thomas Mann: Queen Elizabeth II Graduate
Research Scholarship
Departmental Graduate Student Excellence
Award

Pedro Martinez: Departmental
Recruitment Scholarship

Research Highlights accelerators (motivated by parking lot construction), financial modeling seed delivery accuracy following breast brachytherapy as
for proton therapy in Alberta, and a review of device approval in North well as tracking seed motion over time.
The division of medical physics has three major research America. Other papers related to decision making in radiotherapy
foci: brachytherapy, hypofractionated treatments and included assessment dose homogeneity constraints in the prostate Lingyue Sun, MSc defended her MSc thesis, “Investigation
decision making in radiotherapy. Many projects cross and the development of frameworks to assess adaptive radiotherapy of Volumetric Modulated Arc Therapy Dosimetry in
between these three foci. This year, major work was conducted protocols and 3D printed materials. Prostate and Head and Neck: from Planning to Delivery”,
on hypofractionated breast radiotherapy. In brachytherapy, this under the supervision of Dr. Wendy Smith and Dr. Charles
is delivered with permanent seed implantation, where several Dr. Elizabeth Watt successfully defended her PhD thesis, Kirkby. It was found that removing the target dose
publications addressed the development of treatment planning “Development of post-implant analysis methodologies for permanent uniformity requirement resulted in better rectum sparing
techniques, the development of phantoms to enable training for breast seed implant”, supervised by Dr. Tyler Meyer. The primary and improved tumor control probability. Secondly, the
the delivery of this challenging technique and the assessment of scientific contribution of this work was the development of an impact of body contour changes on dose distributions for
treatment quality. In hypofractionated breast radiotherapy delivered algorithm to automatically associate seeds identified on post-implant prostate and head and neck VMAT plans was examined.
by external beam, results published. In addition, projects stimulated CT scans with their planned locations, enabling the determination of
by the development for improvement in radiotherapy reviewed and
examined treatment planning techniques, dose calculation algorithms
as well as set up techniques. A number of research projects related
to infrastructure development were also completed in 2018.
Examples include investigations into the effect of vibrations on linear

21 DEPARTMENT OF ONCOLOGY

Palliative Medicine

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Jessica Simon MB ChB, Our division’s clinical and research aims are aligned in seeking to provide Dr. Shane Sinclair: Palliative
MRCP(UK), FRCPC early and ongoing access to coordinated, comprehensive and compassionate Medicine, Paper of the Year.
palliative care to improve quality of life for Albertans with advanced cancer Covenant Health, Palliative
Division Statistics and other illnesses. Our division’s research embraced the Department Of Care Institute, Neil MacDonald
Oncology Research Strategic Plan 2017-2025 with studies that are “… Lectureship Award. University
Staff clinically focused and fully integrated with cancer care at the Cancer Centre” of Toronto, Carmelita Lawlor
24 (Pillar 1 Advancing our Research Foci); “…initiatives that can engage faculty Lectureship in Palliative Care
Publications and staff across Divisions and the Cancer Centre” (Pillar 2 Embracing our Award. University of Calgary,
32 Research Leadership and culture); “Educate and cultivate the next generation Great Supervisor Award.
Grants of researchers” (Pillar 3 Building Capacity, Mentoring and Supporting University of Calgary, Faculty
17 Researchers) and “Promote partnership and collaboration in research of Nursing, Award in Graduate
Value of Grants both within and outside the Department” (Pillar 4 Fostering Team Work Teaching Excellence.
$1,696,777 and Collaboration).
Presentations/ Dr. Amanda Roze Des Ordons:
Symposiums Highlights in education included approval of our Royal College of Physicians University of Calgary
44 and Surgeons sub-specialty palliative medicine residency application, Postgraduate Medical Education
Book Chapters developed by Residency Program Director Dr. Amanda Roze des Ordons, Outstanding Commitment to
3 and a successful CARMS match, with our first resident due to start July 2019. Residency Education Award,
Additionally our first Palliative Care Enhanced Skills resident completed the June 2018.
new Department of Family Medicine one-year program in June 2018 and the University of Calgary Clinical,
program welcomed two new residents in July. Education is a perennial priority Adjunct and Research Award in
of the division, with Dr. Loftus, Deputy Residency Program Director, overseeing Postgraduate Clinical Education,
continued high demand from rotating residents and undergraduate students. May 2018.
We are excited to support the increasing focus on palliative care competencies
embedded in many specialty residency programs. This also creates capacity Dr. Amane Abdul Razzak:
challenges, which we hope to address through development of innovative Division of Palliative Medicine
models of education beyond the typical rotation-based training. Resident Teaching Award,
University of Calgary.

ANNUAL REPORT 2018 22

“Our focus in 2018-19 has been on

strengthening linkages between

oncology, family medicine and

palliative care providers. Together

we don’t just treat cancer, we

treat people” - Dr. Jessica Simon

Members of the Division of Palliative Medicine, Palliative care enhanced skills residents and
palliative teaching partners at the annual division education retreat Nov 2018

Clinical Highlights Research Highlights In Advance Care Planning research,
(www.ACPCRIO.org) we completed a provincial audit
Division members serve in Palliative and End of Life Our CIHR PHSI sponsored project - Palliative Care of hospitalized patients’ experience with goals of care
Care, Alberta Heath Services, Calgary Zone, supporting Early and Systematic (www.PaCESProject.ca) - communication, finding only 30% awareness of having
year on year growth, with about 5900 consults in completed three reports for Alberta Health that a goals of care designation and about 60% agreement
2018 (50% of which were for cancer diagnoses and are essential to understanding why palliative care between those orders and patient preferences. Through
around 500 were Complex Cancer Consults seen by services have been accessed late in Alberta. We a national research collaborative (www.iCAN-ACP.ca)
the palliative care team in Tom Baker Cancer Centre) also launched the guideline, pathway and resources seeking to address these quality and safety gaps, we
and 542 Intensive Palliative Care Unit admissions. for “Integrating an Early Palliative Approach into successfully adapted and implemented the Serious
The Clinical Alternative Relationship Plan for Palliative Advanced Colorectal Cancer Care” and completed Illness Care Program into Unit 36, Foothills Medical
Care was awarded an expansion to facilitate growth in one-year baseline data collection for the Living with Centre. Those attending physicians are now conducting
underserved populations such as Long term care, liver Colorectal Cancer study. This collaborative project two serious illness care conversations per week, with
failure and increased demand at the cancer centre. with GI oncologists and family physicians aims patients reporting significant increases in feeling heard
to improve quality of life for Albertans living with and understood by their healthcare providers and 84%
advanced colorectal cancer. finding the conversations worthwhile.

23 DEPARTMENT OF ONCOLOGY

Pediatric Oncology

Overview Awards and Achievements

Section Chief and/or Alberta Children’s Hospital’s Blood and Marrow Transplant Program received the ‘Alberta Health 4 nominations for AHS
Division Head: Services’ President’s Excellence Award’ for outstanding achievements in research and innovation, President’s Awards (Drs. Victor
Dr. Victor A. Lewis, MD for work in sickle cell transplantation and primary immune deficiency transplantation. New Lewis, Tony Truong & Greg
non-toxic and reduced toxicity regimens were introduced starting 2013 and to date both initiatives Guilcher for the BMT Team,
Division Statistics boast survival rates in excess of 95%. Each program has facilitated substantial local, national and and Dr. Lucie Lafay-Cousin for
international collaborations. The success of the sickle cell program has allowed local investigators outstanding achievement in
Staff to gain international leadership status and local data have aided the development of international patient and family centred care
9 collaborative studies related to transplantation as well as supportive care for treatment of patients with ‘Hospital At Home Program’)
Publications sickle cell disease. The pediatric program performed the ‘first in Canada’ aẞ T-cell receptor depleted
22 haploidentical hematopoietic stem transplant. Since then the program has successfully performed four President’s Excellence Award
Grants additional transplants. Dr. Ravi Shah who joined our section as a 0.6 FTE locum was instrumental is for Outstanding achievements
35 moving this platform forward. His research interests in primary immune deficiency and haploidentical in Innovation and Research
Value of Grants transplantation are a special asset to the program. (Winner): Drs. Victor Lewis,
$161,298 Greg Guilcher and Tony Truong
Presentations/ The ‘Hospital at Home program’ for children in pediatric oncology continues to grow and succeed in its
Symposiums primary goal to provide care, including chemotherapy in the comfort of patient’s homes. The program President’s Excellence Award
27 was nominated for the ‘President’s excellence award’ for 2018. While clinical care was the main focus for Patient and Family Centered
Book Chapters since inception, the research platform continues to evolve and the first study evaluating the benefits of Care (Nominated)
2 in-home provision of care, inclusive of psychosocial benefit and cost effectiveness is underway. Dr. Lucie-Lafay Cousin

Dr. Douglas Strother successfully initiated the ‘ReRAD’ study evaluating ‘re-radiation in brain tumor
patients’. As an international initiative this continues to demonstrate our leadership role within
neuro-oncology. Dr. Lafay-Cousin and Dr. Strother remain heavily involved in national and international
projects that advance the care for children with brain tumors. Dr. Strother remains the local principal
investigator for the Children’s Oncology Group, our largest collaborative partner.

Dr. Tony Truong completed a successful sabbatical year at the Hospital for Sick Children in Toronto.
Working with the ‘Cancer in Young People in Canada’ database, he was able to put forward several
landmark publications with others under review. The sabbatical will allow continued involvement
with that research group and ability to introduce local colleagues and trainees to a similar research
experience. Dr. Truong will now focus on the development of electronic medical record implementation
working through a dedicated position within Connect Care. He will continue to hold a clinical role
as well.

ANNUAL REPORT 2018 24

The program graduated two R6 residents this year.
Two residents joined at the R4 level while three
subspecialty fellows joined our program for further
training in blood and marrow transplantation (x2)
and one for general hematology and oncology.

Research Highlights “Pediatric Oncology, Blood and Marrow Transplantation, continues
its effort to introduce innovation into practice. Advancement of
Precision Oncology for Young People (PROFYLE), a precision medicine in basic science and clinical medicine is our
pan-Canadian effort funded by the Terry-Fox foundation goal. We continue to take steps to make excellence our habit.”
received IRB approval and is fully open to enrollment of
patients. The Pediatric Oncology Experimental Therapeutic - Dr. Victor Lewis
Investigator Consortium (POETIC), continues to evolve as
an international study and will open shortly as our second
precision medicine platform. Both studies will allow access to
genetic testing for difficult to treat and refractory tumors with
enhance the ability for patients to receive targeted therapy.

Children’s Oncology Group enrollments continue on open
studies while we continue to open studies in collaboration
with Industry and various Canadian and US partnerships. The
program saw a significant change in research staff in 2018
and the resultant slowing in activity. That has since been
rectified and our research unit activity is back to normal

Calgary continues to hold the annual Sickle Cell Transplant
Alliance consortium (STAR) and POETIC groups meetings
in Banff. Such meetings increase our stance and visibility in
respective research consortia. Work through the Sickle cell
and primary immune deficiency initiative are being presented
at local, national and international forums.

25 DEPARTMENT OF ONCOLOGY

Preventive Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Christine Friedenreich, In 2018, the Division of Preventive Oncology had 14 members that includes the Dr. Darren Brenner was awarded
PhD, FCAHS Research Scientists in the Department of Cancer Epidemiology and Prevention the Department of Oncology’s New
Research (CEPR) at Alberta Health Services who are Drs. Darren Brenner, Investigator Award.
Division Statistics Miranda Fidler-Benaoudia, Christine Friedenreich, Karen Kopciuk, Cheryl Peters,
Lin Yang and former members of the Department Drs. Nigel Brockton (American Dr. Christine Friedenreich was
Staff Institute of Cancer Research, Arlington VA) and Ilona Csizmadi (Cedars-Mt Sinai, elected as the Chair of the Scientific
14 Los Angeles). Other members include: Dr. Heather Bryant, (Canadian Partnership Council, International Agency for
Publications Against Cancer, Toronto), Dr. Lorraine Shack (Director, Cancer Surveillance of Research on Cancer, World Health
61 CancerControl Alberta, AHS), Dr. Jeff Vallance (Professor, Athabasca University, Organization, Lyon, France (2020-
Grants Medicine Hat), Ms. Xanthoula Kostaras (Manager, Guidelines Utilization Resource 2021).
32 Unit, CancerControl Alberta) and Ms. Melissa Shea-Budgell (Lead, Research
Value of Grants Strategy and Partnerships, Arnie Charbonneau Cancer Institute, Cumming School Dr. Heather Bryant received the
$28,908,254 of Medicine). Our Division also had two postdoctoral fellows, Dr. Jessica McNeil Calum Muir prize from the UICC.
Presentations/ (supervisors: Drs. Friedenreich and Brenner) who holds CIHR and AI postdoctoral
Symposiums fellowships and Dr. Gyanendra Pokharel who was funded by a CIHR grant
74 (supervisor: Dr. Karen Kopciuk). Dr. Cheryl Peters was recruited as a new Research
Book Chapters Scientist in the Department of CEPR and joined the Division in March, 2018.
3 Dr. Miranda Fidler-Benaoudia joined the Department of CEPR in October, 2018
and Dr. Lin Yang in November, 2018. The main areas of focus will be to increase
the research productivity and impact of the research in cancer prevention and to
work collaboratively with other groups in Alberta.

ANNUAL REPORT 2018 26

Research Highlights “We were delighted with the recruitment of three new Research

The Division scientists’ research continues to be focused Scientists to our Division in 2018. Dr. Cheryl Peters is a well-established
on a range of topics in cancer epidemiology and prevention
with a major emphasis on lifestyle factors, occupational and cancer epidemiologist specializing in occupational and environmental
environmental risk factors, descriptive cancer epidemiology,
molecular and genetic mechanisms of cancer etiology and cancer who brings years of experience in this field to her position in
survival. In addition, research is on-going in areas of health
services, cancer surveillance, and cancer survivorship. For Alberta. Dr. Miranda Fidler-Benaoudia is a cancer epidemiologist with
the reporting period of January 1, 2018 to December 31,
2018, our Division members have held 32 grants worth a international training and capacity in cancer surveillance particularly
total of $28,908,254. In addition, they have published 61
papers and made 74 presentations at scientific meetings. for adolescent and young adult cancers which is a priority area for the
The Division scientists have been successful in securing
new funding during this past year particularly from the Department of Oncology. Finally, Dr. Lin Yang is a physical activity
Canadian Institutes of Health Research (CIHR), Natural
Sciences and Engineering Research Council (NSERC) and and cancer epidemiologist also with remarkable international training
the Cumming School of Medicine. One large on-going project
being co-led by Drs. Brenner and Friedenreich, funded by and experience who will add depth to our research in energy balance
the Canadian Cancer Society Research Institute, is the
ComPARe project that is quantifying the current and future and cancer. These three scientists are adding much needed capacity
burden of cancer attributable to lifestyle, environment, and
infections in Canada. Other large cohort studies in breast to our research programs and each have excellent track records and
cancer survivorship are on-going (Alberta Moving Beyond
Breast Cancer (AMBER) Cohort study and the Breast to Bone great potential to enhance the impact and significance of our research
Metastases study). New funding to complete the AMBER
cohort study recruitment and follow-up was received this programs in Preventive Oncology.” - Dr. Christine Friedenreich
year in a nearly $2 million grant from CIHR. Additional
notable new studies that were funded this year include
projects led by Dr. Cheryl Peters in occupational cancer
epidemiology funded through the ministries of labour in
Alberta, Ontario and BC as well as the on-going CAREX
project funded by the Canadian Partnership Against Cancer.

27 DEPARTMENT OF ONCOLOGY

Psychosocial Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Barry D. Bultz, AOE, In 2018, the Division of Psychosocial Oncology continued to demonstrate its commitment to Dr. Barry Bultz: President Emeritus
PhD, Professor scholarship, person-centred clinical care, and leadership in education. International Psycho-Oncology
Society.
Division Statistics Throughout 2018, the Division was able to offer supervision and mentorship to a number
of students and post-doctoral fellows. Dr. Barry Bultz provided mentorship to practitioners Dr. Brian Kelly: The Bernard Fox
Staff and scholars around the world, including Dr. Matilda Ong’Ondi, Medical Oncologist, Kenyatta Award, International Psycho-Oncology
17 National Hospital, Kenya, and Dr. Sana Kazim, Psychiatry, Rashid Hospital, United Arab Society (IPOS). This award honors
Publications Emirates. In 2018, Dr. Linda Carlson provided supervision and training to 11 undergraduate an IPOS or psycho-oncology
68 volunteers, 7 undergraduate students (honours and summer students), 3 graduate students, community member who has made
Grants and 2 postgraduate fellows. Dr. Janet de Groot’s commitment to leadership in medical an outstanding contribution in
35 education was demonstrated through her role as supervisor to PhD and MD students, and education or research to the field of
Value of Grants through a number of international presentations, including the AMEE 2018 Accreditation for psycho-oncology. 2018.
$5,065,383 Healthcare Professions Summit in Basel, Switzerland.
Presentations/ Dr. John Robinson: Department of
Symposiums With generous support from the Daniel Family Foundation, we were able to continue our Oncology, Team Innovation Award
92 efforts toward high-level scholarship, knowledge-translation activities, and clinical care. In (Oncology and Sexuality, Intimacy and
Book Chapters 2018, members of the Division of Psychosocial Oncology published over 60 peer-reviewed Survivorship – OASIS). 2018.
5 articles and book chapters. Dr. Laura Labelle moved into a new role as Supportive Care Lead,
South, CancerControl Alberta. Through her leadership and commitment to person-centred, Dr. Fiona Schulte: International
precision supportive care, the Division has been able to add new clinical staff members Society of Pediatric Oncology (SIOP)
and further strengthen its supportive care programs. With support from the Daniel Family Young Investigator Award. 2018.
Leadership Chair, the Division also hosted a number of visiting scholars, including Professors International Psycho-Oncology
Richard Fielding and Wendy Lam from the University of Hong Kong, Dr. Elizabeth Fradgley, Society (IPOS) Hiroomi Kawano New
Postdoctoral Fellow, University of Newcastle, Australia, and Dr. Gail Garvey, Senior Principal Investigator Award. 2018.
Research Fellow, Menzies School of Health Research. Dr. Garvey and Dr. Angeline Letendre
from Alberta CancerControl focused their presentation on Research strategies to improve Dr. Michael Speca: Department
cancer outcomes in Indigenous Australians & Cancer Prevention & Screening in Alberta of Oncology, Gavin Stuart Award
Indigenous Populations. for Clinical Excellence and
Professionalism. 2018.

Dr. Lauren Walker: Department of
Oncology, Team Innovation Award
(Oncology and Sexuality, Intimacy and
Survivorship – OASIS). 2018.

ANNUAL REPORT 2018 28

Finally, our Division was reviewed by an “Improving the lives of people
International External Advisory Board for the living with cancer through
Arnie Chabonneau Cancer Research Institute and clinical research, education
was described as a national leader in Psychosocial and implementing results into
Oncology. In short, the Advisory Committee stated clinical care.” - Dr. Barry Bultz
that our model of research led to changes in
cancer care delivery. Simply stated, the Advisory
Board said The Division of Psychosocial Oncology
consistently “hit it out of the park”.

Research Highlights

• Dr. Tavis Campbell has been invited to work on an
ongoing monthly basis with the Enoch Cree Nation
to provide teaching and training on management of
chronic disease.

• Dr. Linda Carlson received the “Eyes High”
Postdoctoral Fellow, University of Calgary, Division
of Psychosocial Oncology, Department of Oncology,
Cumming School of Medicine. A new Postdoctoral
Fellow will be joining her lab in June, 2019.

• Dr. Carole Mayer completed her second year
term as President of the Canadian Association of
Psychosocial Oncology, and was invited to present
on best practices (Screening for Distress as the
6th Vital Sign) at the American Society of Clinical
Oncology (ASCO) 2018 Annual Conference in
Chicago, Illinois.

29 DEPARTMENT OF ONCOLOGY

Radiation Oncology Awards and Achievements

Section Chief and/or Overview Dr. Corinne Doll: National Cancer Institute
Division Head: Director’s Service Award
Dr. Lisa Barbera, MD The division welcomed three new members in 2018.
FRCPC Dr. Lisa Barbera joined from the University of Toronto and Dr. Peter Craighead: Foothills Medical Centre
the Sunnybrook Odette Regional Cancer Centre as the new Outstanding Achievement Award
Deputy Section Chief and/or division head. She is an internationally recognized health Preceptor of the Year Award, University
Division Head: services researcher and is working clinically with the breast of Calgary
Dr. Elizabeth Kurien, MD CM group. Dr. Natalie Logie graduated from the University of
FRCPC Alberta residency program and completed a proton and Dr. Rishi Sinha: 2018 Resident Quality of Life
pediatric oncology fellowship in the US. She has joined the Award, University of Calgary Radiation Oncology
Division Statistics breast and pediatric sites. Dr. Muhammad (Salman) Faruqi
graduated from the University of Toronto Radiation Oncology Clinical Highlights
Staff training program in 2017 with a subsequent fellowship in
22 CNS at Sunnybrook Hospital. He has joined the Neuro and Our academic accomplishments have occurred in the
Publications Cutaneous sites. setting of continued clinical growth. Members of the
46 division of radiation oncology saw over 4700 consults in
Grants 2018 which is the 5th consecutive year of volume increase.
10 We are strengthening collaborations with our partners
Value of Grants from medical physics and radiation therapy to improve the
$771, 823 way we conduct our clinical work.
Presentations/
Symposiums
55

ANNUAL REPORT 2018 30

Research Highlights “We will continue to advance the delivery
of personalized radiotherapy as part of a
Two new programs of research were developed in comprehensive person-centred approach
2018. The Person Centred Radiation Oncology Service to care. We will embody the values of
Enhancement (PROSE) program began. This program professionalism, respect, diversity and
aims to use research and quality improvement methods compassion in our daily work.”
to improve the experience of patients coming through
the department of radiation oncology. It hired its first - Dr. Lisa Barbera
staff member and started the foundational work for
program development.

The brachytherapy program received external funding
to support a new program of research. Cervix cancer
patients will now have the ability to participate in the
EMBRACE trial which is an international collaboration
to evaluate the impact MRI guided brachytherapy.
Secondary studies with biologic endpoints are also
planned for our local dataset. A cost benefit analysis of
two different types of prostate cancer brachytherapy
will be conducted. Novel applications of US and MRI will
also be evaluated in the brachytherapy context. This
program of research exemplifies the multidisciplinary
collaboration of radiation oncology, medical physics and
radiation therapy.

31 DEPARTMENT OF ONCOLOGY

Surgical Oncology

Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Greg McKinnon MD, The Division of Surgical Oncology consists of a Dr. Lloyd Mack completed his term as the
FRCSC multidisciplinary group of surgeons dedicated to president of the Canadian Society of Surgical
cancer care as their primary goal. Five members Oncology and was appointed to the Alberta
Division Statistics are located full-time in the Tom Baker Cancer Cancer Control Executive leadership. He also
Centre (TBCC) and three of these are primary became acting deputy head of the Dept. of
Staff appointments to the Department of Oncology with Oncology and received the PGME Appreciation
9 cross-appointment to Surgery. All other members Award for Outstanding Commitment to
Publications are primarily appointed to the Department of Residency Education.
43 Surgery and are located at various sites. The division
Grants of surgical oncology continued to play a leading Dr. May Lynn Quan received the Dept. of
12 role in cancer surgery on many levels. 2018 saw Surgery Health Services Award.
Value of Grants the retirement of Dr. Temple, a leader who will be
$7,466,159 missed by the entire department.
Presentations/
Symposiums
13
Book Chapters
3

Clinical Highlights Research Highlights

Drs. Quan and Temple-Oberle have led the provincial initiative in breast • Dr. Temple-Oberle initiated a study testing the utility of the Kent Imaging Device (a specialized camera for measuring
cancer program development for improving quality and access to tissue oxygenation) in predicting potential tissue necrosis in oncological flap cases. The results of this study could improve
care. Dr. Bouchard-Fortier has stepped fully into the role of advanced surgical cancer care and potentially decrease necrosis rates.
G.I. surgeon and introduced laparoscopic HIPEC surgery to Calgary.
Drs. Harvey and Pasieka are world leaders in endocrine surgery and • Dr. Mack received funding from CPAC to initiate a major project : Mobilizing Evidence for Surgical Quality Improvement”.
conduct high volume cutting edge treatment for endocrine cancers,
as well as attracting top-quality trainees to the Endocrine fellowship. • Dr. Bathe continues to supervise one PhD student, two Master’s students and two postdoctoral fellows. Discoveries in
Dr. Bathe continues to lead the provincial G.I. Tumor Group. metabolomics biomarkers are being moved toward commercialization. Work with the Cancer Genome Atlas has led to
several high-profile publications.

ANNUAL REPORT 2018 32

Dr. Walley Temple’s retirement

“The division of Surgical Oncology had an excellent year in

2018. In addition to numerous publication and new research

endeavors, our members led many provincial clinical teams

and continue to attract world-class trainees to our fellowship

program. We expect to welcome new recruitment and fresh

energy in the upcoming year.” - Dr. Greg McKinnon

33 DEPARTMENT OF ONCOLOGY

Precision Oncology Hub

Scientific Director: Overview
Dr. Don Morris, MD, PhD,
FRCPC(2018) The Precision Oncology Hub at the Tom Baker Cancer Center aims to deliver
personalized medicine for each cancer patient. By incorporating molecular
Dr. Paola Neri, MD, PhD profiling through biomarkers discovery and genomic sequencing studies into
(2019) the cancer management and treatment approaches we intend to provide a
better understanding of cancer biology and mechanisms of drug resistance and
Operational Lead: ultimately deliver a better care for cancer patients.
Ms. Rose Farrell, MSc
Strategic Planning
Unit Leads:
Molecular – Dr. JB McIntyre, Several cancer are characterized by a complex molecular pathogenesis and intra- and
PhD inter-tumor heterogeneity. Therefore genomic studies are extremely important for
the understanding of the disease biology in individual patients, the identification of
Functional Tissue Imaging druggable targets and the delivery of a personalized and tailored therapeutics.
Ms. Angela Chan, MSc

Pharmacokinetics
Mr. Bill Kangarloo, MSc

Division Statistics By building a strong team of experts in genomics, immunology and computational
biology we aim to identify changes in the genomes of tumors that drive cancer
Staff progression, identify new targets for therapy and select drugs based on the genomics
8 profile of the tumor. Those approaches are critical to guide selection of combination
therapies for cancer patients, minimize the use of potentially ineffective therapeutics
Publications and hence lessen any potentially harmful side effects of administered therapeutics.
10
Furthermore, in the field of immunotherapy, that has entered the forefront as a
Grants leading area of ongoing research and promising therapies for a variety of cancers,
6 we intend to develop methods to better understand the mechanisms deregulating
the immune fitness of cancer patients. Those approaches will help to enhance our
Value of Grants understanding of the mechanisms mediating the immune tolerance in cancer patients,
$500,000+ identify and validate diagnostic markers (predictive and/or prognostic) of the immune
“health” status of cancer patients with the aim to implement novel means to reverse
Presentations/ immune tolerance.
Symposiums
15

ANNUAL REPORT 2018 34

Our main goal is to become the hub for clinical and translational research and to work
together with different tumor group leaders, variable university of Calgary institutes
(Arnie Charbonneau Cancer Institute), industries and the TBCC clinical trial unit to
speed the translation of research discovery into improved patient care.
Undoubtedly this approach will align with the current mandate and vision of
personalized medicine delivery at the Tom Baker Cancer Center and will lead to our
patients benefitting from excellent clinical care, access to novel research and studies.

Research Highlights Major Objectives “By becoming the hub for clinical and
translational research, our goal is to
• Acquisition of new platforms such as the • Foster immune-oncology discovery and facilitate the translation of research
Life technology S5 sequencer for bulk drug development discovery into improved patient care.”
genomic analysis and the Perkin Elmer Vectra
Polaris enabling up to 10 color multiplex • Develop in a CLIA-certified clinical environment - Dr. Paola Neri
immunofluorescent immunohistochemistry for standardized procedures to enable routine
the study of the tumor microenvironment. linking of molecular and genomic data with
clinical decision making
• Development and contribution in more than
20 research projects in collaboration with • Integrate research and development of assays
researchers belonging to the Arnie Charbonneau into clinical practice
Cancer Institute, the Department of Oncology,
and Calgary Lab Services.

• The lab members had authorships on
10 different peer reviewed journal article
publications over the 2018 reporting period
and presented their research projects in several
national and international symposia.

• The Pharmacokinetics unit continues to provide
clinically accredited testing for patients while
conducting research activities.

35 DEPARTMENT OF ONCOLOGY

Oncology Research Office

Lead: Overview Highlights
Christie Farrer,
Research Associate The research funding environment and complexity of research in The inaugural Oncology Research Office (ORO) Seed
general is driving the need for researchers to collaborate. We are Grant competition was a huge success and we would like
identifying themes and platforms which will attract researchers to to thank each of the applicants and associated teams for
work together on addressing complex challenges. As such, a variety their tremendous effort and thoughtful submissions . This
of programs and resources have been developed to facilitate high grant opportunity was designed to generate multi and cross
quality multi-disciplinary research within the department. disciplinary teams and this certainly came through in the
applications. The review committee was impressed by the broad
We successfully ran our inaugural ORO Seed Grant competition, disciplines that were represented in cohesive and structured
awarding four multi-disciplinary teams with seed grant funding. applicant teams. We would also like to express our gratitude
Other notable initiatives include the development of an Internal Peer to the members of the review committee for their time and
Review process, monthly research staff learning opportunities, and invaluable expertise in reviewing the submissions. 
development of a comprehensive summer student program. In the
near future we will utilize a research management system in order The winners of this year’s competition: 
to inventory all research activities within the Department in order to
identify gaps and provide tailored support. • Adolescent and Young Adult: The harms of thyroid cancer
overdiagnosis and overtreatment: an investigation of
We will continue to establish ourselves as a research support center late effects in adolescent and young adult thyroid cancer
to support investigator-initiated research, including assistance survivors — PI: Dr. Miranda Fidler
with grant proposals, REB, statistical consultation and project
management. We will continue to provide forums and mechanisms • Survivorship: Occupational Therapy and Exercise for
for researchers to share research interests and opportunities, Survivors with Cancer Fatigue Impacting Return to
while leveraging resources across Alberta Health Services and Work — PI: Dr. Marc Webster
the University of Calgary. Our goal is to secure and develop new
resources to support recruitment, infrastructure, collaboration and • Patient Reported Outcomes: The feasibility of an exercise
innovation within the Department of Oncology. and nutrition supportive care (palliative) intervention for
advanced non-small cell lung cancer —  PI: Dr. Nicole
Culos-Reed and co-PI: Dr. Amane Abdul-Razzak

• Primary Care Integration: Understanding the
diagnostic interval in patients with pancreatic
cancer in Alberta — PI: Dr. Safiya Karim

ANNUAL REPORT 2018 36

Research Highlights “The mandate of the Oncology Research Office (ORO) is to
drive the agenda of the Department of Oncology’s research
Five multi-disciplinary research working groups were created to meet pressing strategic plan. Our goal is to increase research capacity
research challenges, with each group successfully obtaining funding for their by promoting academic research productivity, seeking
respective projects: and creating funding opportunities, and developing
opportunities for collaboration. Our culture fosters
1. Quality Metrics and Quality Improvement – Chair: Dr. Vanessa Krause innovation, partnerships, the cross pollination of ideas,
and strives for excellence in all research activities.”
2. Choosing Wisely – Chairs: Dr. Winson Cheung and Dr. Barry Bultz
- Christie Farrer
3. Integrative Oncology – Chair: Dr. Safiya Karim

4. Global Oncology – Chair: Dr. Walley Temple

5. Health Economics and Cost-Effectiveness – Chair: Dr. Anna Cameron

37 DEPARTMENT OF ONCOLOGY

Calgary Cancer Project

Vision What Sets the Calgary
Cancer Centre (CCC) Apart
The vision of the Calgary Cancer Centre (CCC) is to deliver leading,
comprehensive cancer care that integrates patient and family centred • The extensive scope and integration of cancer care services at the CCC will make
care, education, prevention, screening and cancer research. it one of the most comprehensive academic cancer center in the world

Guiding Principles • Deployment of integrated research across the spectrum will optimize care with
focus on prevention, early detection, precision medicine and psychosocial care
To provide patient and family centred care
• Service delivery will follow an integrated inter-disciplinary care team model, and
To attract, retain and empower staff will include supportive care

To support the discovery and delivery of high quality cancer care • Design is focused on delivering an enhanced patient and staff experience; this
has influenced many design features such as private IPU beds, inclusion of quiet
To operate efficiently spaces, access to natural light in many clinical spaces, courtyards designed to
promote collaboration and wellness
To provide a high level of safety for all patients, staff and visitors
• The design also provides necessary flexibility for the future to support and
To achieve high quality architecture and design accommodate leading edge changes in cancer care.

To support future change in cancer care Design Development Highlights for 2018

• Reviewed over 6,000 drawings

• Facilitated over 500+ design user group meetings

• Participated in the review of 10 mock-up rooms (fully built)

• Completion of 50% design development in October 2017 – May 2018

• Completion of 75% documentation: May – November 2018

• Initiation of 100% documentation: November 2018 – present

ANNUAL REPORT 2018 38

Patient & Family Involvement Patient and Family Engagement Team
Project Management Office Team
• Project team has worked closely with Patient & Family Advisors throughout design
development to ensure that the CCC provides a welcoming and healing environment

• Engagement has been through a variety of activities including participation in focus
groups, design review meeting, monthly committee meetings, digital stories, etc.

• Throughout 2018, there was consistent engagement of the Patient and Family
Advisory Committee (PFAC); this committee is made up of 14 Patient & Family
Advisors who are passionate about the vision of the CCC, as well as current
operations at TBCC.

Construction Milestones

• Construction went from excavation in January 2018 to the pouring of concrete up
Level B2 by the end of the year. To give context, there are 5 levels of parkade below
ground.

• All four cranes were installed by October 2018

• Construction of the first clinical area took place in December 2018, with the setting
of the B2 Level Radiation Therapy slab

• Last major foundation concrete pour was in October 2018

• Construction status as of December 2018
• Up to 320 workers were on site
• Level B5 - Below grade services, columns, walls and slab on grade were
almost complete
• Level B4 & B3 - Suspended slab, columns and walls was progressing well
• Level B2 - Formwork in progress and slab reinforcement was underway

39 DEPARTMENT OF ONCOLOGY

Site construction – March 2018

Foundation Rocks – To mark the milestone of the last major
foundation concrete pour, patient & family advisors and staff
were invited to the construction site and stones inscribed with
names and personal messages of hope were tossed into to the
foundation – October 2018

Site construction – May 2018

ANNUAL REPORT 2018 40

B5 5 Construction – drone view – June 2018 Concrete slab forming – September 2018

First clinical area concrete slab – Radiation Final view of the site for the 2018 year
– November 2018

41 DEPARTMENT OF ONCOLOGY

Department Of Oncology Members

Amane Abdul-Razzak Ted C. Braun Jennifer A. Cobb Rosmin Esmail Petra Grendarova Brian J. Kelly
Clinical Assistant Professor Clinical Professor Associate Professor Adjunct Lecturer Clinical Assistant Professor Adjunct Professor

Nimira S. Alimohamed Darren M.R. Brenner Peter Colbert Markus Eszlinger Savraj S. Grewal John J.P. Kelly
Clinical Assistant Professor Assistant Professor Clinical Assistant Professor Research Associate Professor Associate Professor Assistant Professor

Ronald A. Anderson Malcolm L. Brigden Simon J. Colgan Doreen A. Ezeife Sean C. Grondin Marc Kerba
Associate Professor Clinical Associate Professor Clinical Lecturer Clinical Assistant Professor Professor Clinical Associate Professor

Steve J. Angyalfi Christopher B. Brown Peter S. Craighead David W. Falk Gregory M.T. Guilcher Charles J. Kirkby
Clinical Associate Professor Professor Clinical Professor Clinical Lecturer Associate Professor Adjunct Associate Professor

John P. Arlette W. Donald Buie S. Nicole Culos-Reed Muhammad S. Faruqi Desirée Hao Karen A. Kopciuk
Clinical Professor Professor Adjunct Professor Clinical Assistant Professor Associate Professor Adjunct Associate Professor

Fredrick D. Ashbury Barry D. Bultz Andrew S. Daly Miranda M. Fidler Adrian Harvey Xanthoula Kostaras
Adjunct Associate Professor Professor Clinical Associate Professor Adjunct Assistant Professor Clinical Associate Professor Adjunct Lecturer

Nizar J. Bahlis Kelly W. Burak Indraneel Datta Eleanor L. Foster Daniel Y. C. Heng Vanessa S. Krause
Associate Professor Professor Clinical Associate Professor Clinical Lecturer Clinical Professor Clinical Assistant Professor

Chad G. Ball J. Gregory Cairncross Jeffrey C. Dawes George J. Francis Jan-Willem Henning Elizabeth C. Kurien
Clinical Associate Professor Professor Clinical Lecturer Clinical Assistant Professor Clinical Assistant Professor Clinical Associate Professor

Alexander G. Balogh Tavis S. Campbell Janet M. de Groot Christine M. Friedenreich Gilian C. Ho Habib A. Kurwa
Clinical Associate Professor Adjunct Assistant Professor Associate Professor Adjunct Professor Clinical Lecturer Clinical Professor

Robyn N. Banerjee Jeffrey Q. Cao Paula A. de Robles Lyle D. Galloway Alana Hudson Laura E. Labelle
Clinical Associate Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Lecturer Adjunct Lecturer Adjunct Assistant Professor

Lisa C. Barbera Cynthia M. Card William G. deHaas Michelle N. Geddes Jacqueline Y-T Hui Martin J. LaBrie
Clinical Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Associate Professor Clinical Assistant Professor Clinical Assistant Professor

Oliver F. Bathe Linda E. Carlson Douglas J. Demetrick Gary A.J. Gelfand J. Brad Hunter Lucie Lafay-Cousin
Professor Professor Professor Clinical Associate Professor Clinical Lecturer Associate Professor

Tara L. Beattie Carole R. Chambers Marisa L. Dharmawardene Esmaeel Ghasroddashti Siraj Husain René Lafrenière
Associate Professor Adjunct Assistant Professor Clinical Assistant Professor Adjunct Assistant Professor Clinical Assistant Professor Professor

D. Gwyn Bebb Jennifer A. Chan Elijah Dixon Prafull Ghatage Seema Hussain Johannes C. Lategan
Associate Professor Associate Professor Professor Professor Clinical Assistant Professor Clinical Assistant Professor

Tarek A. Bismar Shamir Chandarana Corinne M. Doll Abhijit Ghose Amal R. Imbulgoda Harold Y. Lau
Professor Clinical Associate Professor Clinical Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Professor

Walter B. Blahey Srinivasa (Srini) Chary Bryan J. Donnelly Janine Giese-Davis Deirdre A. Jenkins Adrienne Lee
Clinical Associate Professor Clinical Assistant Professor Clinical Assistant Professor Adjunct Associate Professor Clinical Associate Professor Clinical Assistant Professor

Pinaki Bose M. Ahsan R. Chaudhry Joseph C. Dort Sarah J. Glaze L. Martin Jerry Susan P. Lees-Miller
Adjunct Assistant Professor Clinical Assistant Professor Professor Assistant Professor Honorary Clinical Professor Professor

Antoine Bouchard-Fortier Tina Cheng Scot D. Dowden Aaron A. Goodarzi Victor H. Jimenez-Zepeda Richard M. Lee-Ying
Clinical Assistant Professor Associate Professor Clinical Associate Professor Assistant Professor Clinical Assistant Professor Clinical Assistant Professor

M. Avis Boyar Winson Y.T. Cheung Peter R. Duggan Geoffrey T. Gotto Hatim Karachiwala Laurie Lemieux
Clinical Lecturer Associate Professor Clinical Associate Professor Clinical Associate Professor Clinical Assistant Professor Clinical Lecturer

Vivien H.C. Bramwell-Wesley Pamela Chu Jacob C. Easaw Andrew J. Graham Safiya Karim Victor A. Lewis
Clinical Professor Associate Professor Adjunct Associate Professor Clinical Associate Professor Clinical Assistant Professor Associate Professor

ANNUAL REPORT 2018 42

Gerald Lim Tyler S. Meyer Nicolas P. Ploquin Donna L. Senger Jan Storek Jeff K. Vallance
Clinical Assistant Professor Adjunct Assistant Professor Adjunct Assistant Professor Research Associate Professor Professor Adjunct Assistant Professor

Hong W. Liu Michael J. Monument Man-Chiu Poon Lorraine G. Shack Douglas R. Strother Franciscus A. van der Hoorn
Adjunct Assistant Professor Assistant Professor Clinical Professor Adjunct Assistant Professor Associate Professor Professor

Shaun Loewen Jose G. Monzon Dwip M. Prajapati Mona Shafey Amirali Surmawala Sunil Verma
Clinical Assistant Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Associate Professor Clinical Lecturer Professor

Russell G. Loftus Donald G. Morris May Lynn Quan Melissa A. Shea-Budgell Francis R. Sutherland Lauren M. Walker
Clinical Lecturer Professor Associate Professor Adjunct Assistant Professor Professor Adjunct Assistant Professor

Natalie A. Logie Lindy Murphy Sarah E. Quirk Jessica E. Simon Rachel M. Syme Barbara A. Walley
Clinical Assistant Professor Clinical Lecturer Adjunct Assistant Professor Associate Professor Adjunct Assistant Professor Adjunct Associate Professor

Sasha M. Lupichuk Aru Narendran Harvey C. Quon J. Steven A. Simpson Vincent C. Tam Edwin Wang
Clinical Assistant Professor Professor Clinical Associate Professor Clinical Associate Professor Clinical Associate Professor Professor

Paul R. MacEachern Jill G. Nation Soundouss Raissouni Shane Sinclair Patricia Tang Eric Wasylenko
Clinical Associate Professor Professor Clinical Assistant Professor Adjunct Associate Professor Clinical Associate Professor Clinical Associate Professor

Lloyd A. Mack Gregory S. Nelson Derrick E. Rancourt S. Richie Sinha Jason Tay Marc A. Webster
Professor Associate Professor Professor Clinical Assistant Professor Associate Professor Clinical Assistant Professor

Enzio Magi Ernesta P. Neri Karl T. Riabowol Aynharan Sinnarajah Walley J. Temple Jane M. Wilson
Clinical Associate Professor Associate Professor Professor Assistant Professor Professor Emeritus Clinical Assistant Professor

Hubert K-M. Marr Nancy A. Nixon Stephen M. Robbins David P. Skarsgard Claire F. Temple-Oberle Michael D. Wong
Clinical Assistant Professor Clinical Assistant Professor Professor Clinical Associate Professor Professor Clinical Assistant Professor

Kevin J. Martell Ivo A. Olivotto John W. Robinson Leslie A. Skeith J.F. (Ted) Thaell Nicola A.M. Wright Clinical
Clinical Assistant Professor Honorary Clinical Professor Adjunct Associate Professor Assistant Professor Clinical Assistant Professor Associate Professor

Celestina Martopullo Carolyn J. Owen Gloria B. Roldan Urgoiti Jiri Slaby Kundan S. Thind Jackson S.Y. Wu
Adjunct Lecturer Associate Professor Clinical Assistant Professor Clinical Assistant Professor Adjunct Assistant Professor Clinical Associate Professor

T. Wayne Matthews Ralf Paschke Michael B. Roumeliotis Michael P. Slawnych Chandini M. Thirukkumaran Lin Yang
Associate Professor Professor Adjunct Assistant Professor Clinical Assistant Professor Research Associate Professor Adjunct Assistant Professor

Jennifer Matthews Janice L. Pasieka Amanda L. Roze des Ordons Wendy L. Smith Bejoy C. Thomas Steven M. Yip
Clinical Lecturer Clinical Professor Clinical Assistant Professor Associate Professor Adjunct Associate Professor Clinical Assistant Professor

Carole R. Mayer A. (Sandy) H.G. Paterson J. Dean Ruether Michael Speca Alain Tremblay V. Wee Yong
Adjunct Associate Professor Honorary Clinical Professor Assistant Professor Adjunct Associate Professor Professor Professor

Sylvia G. McCulloch Guy Pelletier James A. Russell David P. Spencer Theresa Trotter
Clinical Assistant Professor Adjunct Assistant Professor Honorary Adjunct Professor Honorary Adjunct Honorary Clinical
Assistant Professor Associate Professor
Sean McFadden Cheryl E. Peters M. Lynn Savoie
Clinical Assistant Professor Adjunct Assistant Professor Clinical Associate Professor Ronald N. Spice Tony H. Truong
Assistant Professor Assistant Professor
J. Gregory McKinnon Tien Phan Colleen G. Schinkel
Professor Clinical Associate Professor Adjunct Assistant Professor J. MacGregor Steele Chee-Ping Tsai
Clinical Associate Professor Adjunct Assistant Professor
John A. McWhae Tara L. Pickering David C. Schriemer
Clinical Associate Professor Clinical Assistant Professor Professor Douglas A. Stewart Roger Y. Tsang
Professor Clinical Assistant Professor
Daphne J.Y. Mew Greg D. Pierce Fiona S. M. Schulte
Clinical Assistant Professor Adjunct Assistant Professor Assistant Professor

43 DEPARTMENT OF ONCOLOGY

Partners

ANNUAL REPORT 2018 44

P458424

Statement of Early construction Exterior shell NCCC will be substantial
requirements (SOR) activity included construction will be completed by PCL
document confirming excavation, shoring, complete. Operational and handed over to
scope of services and and initial foundation plans and budgets will AHS; operational
service requirements, work. Significant amount commissioning and
was established and of design work was be established. readiness activities,
incorporated into a completed at the 50%
Request for Proposal and 75% levels of design. 2020 including training and
(RFP) submission which move in plans, will be
was released in October. 2018
well underway
2016
2022

2015 2017 2019 2021 2023

Calgary Cancer FP responses were Full design to be Construction activity Calgary Cancer Center
Project (CCP) was evaluated and a contract completed in Spring; will focus on the fit will be operational to
officially announced was awarded to PCL and exterior structure is out of interior spaces. deliver care, and officially
by Government as the their partners DIALOG/ expected to reach the open to patients and
first Design Build (DB) 6th floor above grade. HR activities will
procurement project for STANTEC. First phase High level operational commence, including the the public.
an acute care health of schematic design planning strategy will recruitment of early hires.
facility in Alberta. with extensive user UNIVERSITY OF CALGAR
engagement; official be developed. Operational readiness
ground breaking took plans will be established. CUMMING SCHOOL OF MED
place in early Fall, 2017 Department of Oncology

Department of Oncology
Annual Report 2018